retatrutide nejm 2023 obesity trial ly3437943 just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric Triple hormone receptor agonist retatrutide

Phung OJ, Scholle JM, Talwar M, Coleman CI

As with many things B12 related, we need more and better research on B12 metabolism , on the condition of PA and how to treat it most effectively

Decreased quality of life: Symptoms can make it hard to work and keep up with other responsibilities

Tesamorelin vs Other Peptide Therapies You may have come across other peptides like Semaglutide or AOD-9604 in your research

Proposals for compounding reform are under consideration in California, Colorado and Kentucky

Glossary CKD Chronic kidney disease CVD Cardiovascular disease FDA Food and Drug Administration GLP-1 Glucagon-like peptide-1 GLP-1s Glucagon-like peptide-1 receptor agonists HF Heart failure MASH Metabolic dysfunction-associated steatohepatitis OA Osteoarthritis OSA Obstructive sleep apnea PAD Peripheral arterial disease SC Subcutaneous T2DM Type 2 diabetes mellitus U.S